Fondaparinux
Concept
Vocabulary Service
Overview
subject area of
-
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer Journal Articles
-
A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery. Journal Articles
-
A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialist. Journal Articles
-
A non-anticoagulant synthetic pentasaccharide reduces inflammation in a murine model of kidney ischemia-reperfusion injury Journal Articles
-
Activated Clotting Time and Outcomes During Percutaneous Coronary Intervention for Non–ST-Segment–Elevation Myocardial Infarction Journal Articles
-
Advances and Contemporary Issues in Prophylaxis for Deep Vein Thrombosis Journal Articles
-
Advances and contemporary issues in prophylaxis for deep vein thrombosis. Journal Articles
-
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia Journal Articles
-
Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study Journal Articles
-
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Journal Articles
-
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Journal Articles
-
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Journal Articles
-
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer Journal Articles
-
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer Journal Articles
-
Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes Journal Articles
-
Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes Journal Articles
-
Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines Journal Articles
-
Anti‐PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis Journal Articles
-
Anti‐PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non‐drug risk factors and evidence for a stoichiometry‐based model of immunization Journal Articles
-
Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin Journal Articles
-
Are placebo‐controlled trials ethical in areas where current guidelines recommend therapy? No Journal Articles
-
Benefit of Selective Factor Inhibition Journal Articles
-
Beyond Unfractionated Heparin and Warfarin Journal Articles
-
Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention in Patients with Non‐ST‐Segment Elevation Acute Coronary Syndrome Initially Treated with Fondaparinux: Results from an International, Multicenter, Randomized Pilot Study (SWITCH III) Journal Articles
-
Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia Journal Articles
-
Clinical trials of deep vein thrombosis prophylaxis in medical patients Journal Articles
-
Clinical trials of new anticoagulants. Journal Articles
-
Close Approximation of Two Platelet Factor 4 Tetramers by Charge Neutralization Forms the Antigens Recognized by HIT Antibodies Journal Articles
-
Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes Journal Articles
-
Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia Journal Articles
-
Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)‐5 trial Journal Articles
-
Controversies in Timing of the First Dose of Anticoagulant Prophylaxis Against Venous Thromboembolism After Major Orthopedic Surgery Journal Articles
-
Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Journal Articles
-
Corn trypsin inhibitor coating attenuates the prothrombotic properties of catheters in vitro and in vivo Journal Articles
-
Delayed‐onset HIT caused by low‐molecular‐weight heparin manifesting during fondaparinux prophylaxis Journal Articles
-
Dermatose bulleuse hémorragique probablement associée au fondaparinux Journal Articles
-
Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)–5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non–ST-segment elevation acute coronary syndromes Journal Articles
-
Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review Journal Articles
-
Economic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review Journal Articles
-
Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin Journal Articles
-
Effect of substrate and fibrin polymerization inhibitor on determination of plasma thrombin generation in vitro Journal Articles
-
Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial Journal Articles
-
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment Journal Articles
-
Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines Journal Articles
-
Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention Journal Articles
-
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial Journal Articles
-
Efficacy and safety of fondaparinux in major orthopedic surgery according to the timing of its first administration Journal Articles
-
Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial Journal Articles
-
Emerging anticoagulants for the treatment of venous thromboembolism Journal Articles
-
Evidence-Based Management of Anticoagulant Therapy Journal Articles
-
Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism Journal Articles
-
Flexibility in Administration of Fondaparinux for Prevention of Symptomatic Venous Thromboembolism in Orthopaedic Surgery Journal Articles
-
Fondaparinux Journal Articles
-
Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery Journal Articles
-
Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery Journal Articles
-
Fondaparinux Reduces Long-term Risk of Venous Thromboembolism After Surgery for Hip Fractur Journal Articles
-
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery Journal Articles
-
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery. Journal Articles
-
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double‐blind comparison Journal Articles
-
Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: Outcomes and treatment effect across different levels of risk Journal Articles
-
Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban Journal Articles
-
Fondaparinux for Treatment of Heparin-Induced Thrombocytopenia Journal Articles
-
Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs Journal Articles
-
Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score–matched study Journal Articles
-
Fondaparinux in the management of patients with ST-elevation acute myocardial infarction Journal Articles
-
Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6 Journal Articles
-
Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke Journal Articles
-
Fondaparinux treatment of acute heparin‐induced thrombocytopenia confirmed by the serotonin‐release assay: a 30‐month, 16‐patient case series Journal Articles
-
Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial Journal Articles
-
Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT) – Bridging the River Coumarin Journal Articles
-
Fondaparinux versus enoxaparin for prevention of venous thromboembolism Journal Articles
-
Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic Surgery<subtitle>A Meta-analysis of 4 Randomized Double-blind Studies</subtitle> Journal Articles
-
Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): A randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux Journal Articles
-
Fondaparinux – evolution or revolution in anticoagulant care? Journal Articles
-
Fondaparinux, the first selective factor Xa inhibitor Journal Articles
-
Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy Journal Articles
-
Fondaparinux: does it cause HIT? can it treat HIT? Journal Articles
-
Future therapeutic directions for factor Xa inhibition in the prophylaxis and treatment of thrombotic disorders. Journal Articles
-
HIT complicating fondaparinux prophylaxis: fondaparinux-dependent platelet activation as a marker for fondaparinux- induced HIT Journal Articles
-
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment Journal Articles
-
Heparin-Induced Thrombocytopenia Associated with Fondaparinux Journal Articles
-
Heparin-induced thrombocytopenia: A stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings Journal Articles
-
Heparin‐induced thrombocytopenia – therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4–heparin complexes Journal Articles
-
High‐dose intravenous immunoglobulin to treat spontaneous heparin‐induced thrombocytopenia syndrome Journal Articles
-
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes Journal Articles
-
In reply: Low‐molecular‐weight heparins and heparinoids Journal Articles
-
In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation Journal Articles
-
Incremental Value of Left Ventricular Systolic and Diastolic Function to Determine Outcome in Patients with Acute ST‐Segment Elevation Myocardial Infarction: The Echocardiographic Substudy of the OASIS‐6 Trial Journal Articles
-
Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in Non–ST-Segment Elevation Acute Coronary Syndromes Journal Articles
-
Influence of the duration of fondaparinux (Arixtra®) prophylaxis in preventing venous thromboembolism following major orthopedic surgery Journal Articles
-
Investigations of the effectiveness of heparin variants as inhibitors of histones Journal Articles
-
Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux: The FUTURA/OASIS-8 Randomized Trial Journal Articles
-
Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials Journal Articles
-
Mandatory contrast-enhanced venography to detect deep-vein thrombosis (DVT) in studies of DVT prophylaxis: upsides and downsides Journal Articles
-
Mechanism of Catalysis of Inhibition of Factor IXa by Antithrombin in the Presence of Heparin or Pentasaccharide Journal Articles
-
Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo Journal Articles
-
Minimizing costs for treating deep vein thrombosis: the role for fondaparinux Journal Articles
-
New Anticoagulants for Treatment of Venous Thromboembolism Journal Articles
-
Nonbleeding complications of unfractionated and low-molecular weight heparins. Journal Articles
-
Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia Journal Articles
-
Optimizing Prophylaxis of Venous Thromboembolism Journal Articles
-
Overview of the clinical results of pentasaccharide in major orthopedic surgery. Journal Articles
-
Parenteral Anticoagulants Journal Articles
-
Parenteral Anticoagulants Journal Articles
-
Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review Journal Articles
-
Pentasaccharides Journal Articles
-
Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients Journal Articles
-
Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial Journal Articles
-
Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison Journal Articles
-
Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE Journal Articles
-
Prevention and treatment of venous thromboembolism in the elderly patient. Journal Articles
-
Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines Journal Articles
-
Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial Journal Articles
-
Probable fondaparinux-associated bullous hemorrhagic dermatosis Journal Articles
-
Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study Journal Articles
-
Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study Journal Articles
-
Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention Journal Articles
-
Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes Journal Articles
-
Reversing Anticoagulant Therapy Journal Articles
-
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study Journal Articles
-
Setting a standard for venous thromboembolism prophylaxis Journal Articles
-
Superiority of Fondaparinux Over Enoxaparin in Preventing Venous Thromboembolism in Major Orthopedic Surgery Using Different Efficacy End Points Journal Articles
-
The Editor's Roundtable: Arterial Thrombosis and Acute Coronary Syndromes Journal Articles
-
The design of venous thromboembolism prophylaxis trials: Fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery Journal Articles
-
The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial Journal Articles
-
The safety of fondaparinux for the prevention and treatment of venous thromboembolism Journal Articles
-
The serological profile of fondaparinux-associated heparin-induced thrombocytopenia syndrome Journal Articles
-
Thromboprophylaxis in Medical Patients – Why Not For All? Conferences
-
Use of selective factor Xa inhibitors in special populations. Journal Articles
-
Venous thromboembolism prophylaxis: role of factor xa inhibition by fondaparinux. Journal Articles
-
Voting with your fondaparinux Journal Articles